EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Potential SARS-CoV-2 Main Protease (MPro) Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Approaches

Mohd Yasir Khan iD, Farah Maarfi iD, Abid Ullah Shah, Nithyadevi Duraisamy iD, Mohammed Cherkaoui, Maged Gomaa Hemida iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Mohd Yasir Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digital Engineering and Artificial Intelligence, College of Science, Long Island University, Brooklyn, NY 11201, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, Protease Inhibitors, Antiviral Agents, Viral Nonstructural Proteins. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Agriculture, USDA-NIFA Animal Health and Disease Research, Long Island University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main protease (MPro) of coronaviruses (CoVs) is an essential enzyme involved in viral replication and represents an attractive target for antiviral drug discovery. Based on the similar binding pocket residues within the MPro of different CoVs, this study aimed to identify potential inhibitors of SARS-CoV-2 MPro from PDB ID 6M2N using integrated computational approaches. Interaction-based pharmacophore modeling, virtual screening, molecular docking, MM-GBSA binding energy calculation, and molecular dynamics simulation (MDS) were performed using BIOVIA Discovery Studio. The validated pharmacophore model was utilized to screen the ZINC database, followed by docking and 100 ns MDS analyses of the top-ranked compounds. The pharmacophore model 01 demonstrated favorable predictive performance (AUC = 0.781). Virtual screening identified 483 compounds, from which 15 compounds were selected for docking studies. Among them, ZINC95473654 (Lig-1), ZINC95473725 (Lig-2), and ZINC08792368 (Lig-3) exhibited strong binding affinity toward MPro. Lig-1 demonstrated the best docking score and binding free energy, along with stable interactions with key catalytic residues HIS41, CYS145, and GLU166. MDS analyses further confirmed that Lig-1, Lig-2 and Lig-3 maintained stable conformations. The hydrogen bond distance monitoring and post MDS-MM-GBSA results suggest Lig-1 followed by Lig-3 as an inhibitor for MPro and persistent intermolecular interactions throughout the 100 ns simulation period. The findings suggest that Lig-1, followed by Lig-3, may serve as promising computational lead compounds targeting SARS-CoV-2 MPro, representing promising candidates for further experimental validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Protease InhibitorsAntiviral AgentsViral Nonstructural ProteinsBetacoronavirusMolecular Dynamics SimulationMolecular Docking SimulationPharmacophoreHumansCoronavirus 3C ProteasesBinding SitesProtein BindingCysteine Endopeptidases

Stichwörter der Autor:innen

catalytic dyadcoronaviruses (CoVs)main protease (MPro)molecular dockingmolecular dynamics simulation (MDS)pharmacophore modelingvirtual screening

Substanzen

Protease InhibitorsAntiviral AgentsViral Nonstructural ProteinsCoronavirus 3C ProteasesCysteine Endopeptidases

Autor:innen und Institutionen

  • Department of Digital Engineering and Artificial Intelligence, College of Science, Long Island University, Brooklyn, NY 11201, USA.
  • Department of Veterinary Biomedical Sciences, Lewyt College of Veterinary Medicine, Long Island University, 720 Northern Boulevard, Brookville, NY 11548, USA.

ORCID-Profile: Mohd Yasir Khan, Farah Maarfi, Nithyadevi Duraisamy, Maged Gomaa Hemida

Förderung

  • United States Department of Agriculture
  • USDA-NIFA Animal Health and Disease Research
  • Long Island University

Zitieren

APA

Khan, M. Y., Maarfi, F., Shah, A. U., Duraisamy, N., Cherkaoui, M., & Hemida, M. G. (2026). Identification of Potential SARS-CoV-2 Main Protease (MPro) Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177684

Vancouver

Khan MY, Maarfi F, Shah AU, Duraisamy N, Cherkaoui M, Hemida MG. Identification of Potential SARS-CoV-2 Main Protease (MPro) Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Approaches. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177684

BibTeX
@article{Khan2026,
  author = {Khan, Mohd Yasir and Maarfi, Farah and Shah, Abid Ullah and Duraisamy, Nithyadevi and Cherkaoui, Mohammed and Hemida, Maged Gomaa},
  title = {Identification of Potential SARS-CoV-2 Main Protease (MPro) Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Approaches},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177684}
}
Kostenlos starten →